top of page
OUR DRUG PIPELINE
Promising disease product candidates for difficult to treat diseases
UDP-N-acetylglucosamine—dolichyl-phosphate N-acetylglucosaminephosphotransferase
(DPAGT1)
Email us at info@anviron.com to request more information including our White Paper for Trastuzumab resistant, Her2+ breast cancers.
bottom of page